These Small Quantum Stocks Just Got MILLIONS. Are They Buys?
2 extracted signals · 2 resolved · 0 still active
MarketBeatIndependent analyst profile- Source published
- 01 Jun 2026, 00:30 UTC
- Recorded by Tahlil Plus
- 01 Jun 2026, 01:24 UTC
AI-generated source summary
The video discusses two publicly traded quantum computing stocks, D-Wave Quantum (QBTS) and Rigetti Computing (RGTI), which have recently received significant government funding. D-Wave Quantum is presented as a dual technology player, already selling quantum annealing services on the cloud. Rigetti Computing is highlighted as a full-stack quantum builder, developing supercomputing qubit technology. Both companies have benefited from government grants, with D-Wave receiving funding for its CHIPS Act initiative and Rigetti securing a grant to build its Cepheus system. The analysis suggests a bullish outlook for both QBTS and RGTI, driven by this influx of capital and their advancements in quantum technology. The video implies that these companies are positioned for growth due to their innovative approaches and government support.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
MarketBeat
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.